These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 925922

  • 1. Effect of hemodialysis on cefazolin protein binding.
    Greene DS, Tice AD.
    J Pharm Sci; 1977 Oct; 66(10):1508-10. PubMed ID: 925922
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacology of cefazolin and other cephalosporins in patients with renal insufficiency.
    Craig WA, Welling PG, Jackson TC, Kunin CM.
    J Infect Dis; 1973 Oct; 128():Suppl:S347-5. PubMed ID: 4744016
    [No Abstract] [Full Text] [Related]

  • 3. [Plasma half-life of cefazoline. Study in the normal subject and in the patient with renal insufficiency].
    Humbert G, Fillastre JP, Leroy A.
    Nouv Presse Med; 1975 Oct 18; 4(35):2523-6. PubMed ID: 1196876
    [No Abstract] [Full Text] [Related]

  • 4. Binding rate of antibacterials to serum proteins.
    Greene DS, Quintiliani R, Nightingale CH.
    J Pharm Sci; 1977 Nov 18; 66(11):1663-4. PubMed ID: 915759
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of cefazolin in normal and uremic subjects.
    Welling PG, Craig WA, Gordon AL, Kunin CM.
    Clin Pharmacol Ther; 1974 Apr 18; 15(4):344-53. PubMed ID: 4821438
    [No Abstract] [Full Text] [Related]

  • 6. Comparative plasma bactericidal activity of cephapirin and cefazolin.
    Hottendorf GH, Price KE, Van Harken DR.
    Curr Ther Res Clin Exp; 1975 Aug 18; 18(2):364-70. PubMed ID: 809250
    [No Abstract] [Full Text] [Related]

  • 7. The effects of haemofiltration on cefazolin levels during cardiopulmonary bypass.
    O'Rullian JJ, Wise RK, McCoach RM, Kingsley CP, Williams DR.
    Perfusion; 1998 May 18; 13(3):176-80. PubMed ID: 9638714
    [Abstract] [Full Text] [Related]

  • 8. Cefazolin serum concentrations with fixed intravenous dosing in patients on chronic hemodialysis treatment.
    Kuypers D, Vanwalleghem J, Maes B, Messiaen T, Vanrenterghem Y, Peetermans WE.
    Nephrol Dial Transplant; 1999 Aug 18; 14(8):2050-1. PubMed ID: 10462306
    [No Abstract] [Full Text] [Related]

  • 9. The serum half-life and urine concentrations of cephazolin sodium in patients with terminal renal failure: effect of haemodialysis.
    Eastwood JB, Gower PE, Curtis JR.
    Scott Med J; 1976 Sep 18; 20(5):240-3. PubMed ID: 1265473
    [Abstract] [Full Text] [Related]

  • 10. Blood levels and tissue concentrations of cefazedone in animals.
    Dingeldein E, Wahlig H.
    Arzneimittelforschung; 1979 Sep 18; 29(2a):400-3. PubMed ID: 582715
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and hemodialyzability of cefazolin in uremic patients.
    Craig CP, Rifkin SI.
    Clin Pharmacol Ther; 1976 Jun 18; 19(6):825-9. PubMed ID: 773590
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of cefazolin in patients with renal failure; special reference to hemodialysis.
    Brogard JM, Pinget M, Brandt C, Lavillaureix J.
    J Clin Pharmacol; 1977 Apr 18; 17(4):225-30. PubMed ID: 849996
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
    Leroy A, Canonne MA, Fillastre JP, Humbert G.
    Curr Ther Res Clin Exp; 1974 Sep 18; 16(9):878-89. PubMed ID: 4214662
    [No Abstract] [Full Text] [Related]

  • 14. Cefazolin dosing protocol for patients receiving long-term hemodialysis.
    Ahern JW, Possidente CJ, Hood V, Alston WK.
    Am J Health Syst Pharm; 2003 Jan 15; 60(2):178-81. PubMed ID: 12561661
    [No Abstract] [Full Text] [Related]

  • 15. Hemodialysis of cefazolin.
    McCloskey RV, Forland MF, Sweeney MJ, Lawrence DN.
    J Infect Dis; 1973 Oct 15; 128():Suppl:S358-6. PubMed ID: 4744018
    [No Abstract] [Full Text] [Related]

  • 16. Cefazolin in children with renal insufficiency.
    Hiner LB, Baluarte HJ, Polinsky MS, Gruskin AB.
    J Pediatr; 1980 Feb 15; 96(2):335-9. PubMed ID: 7351609
    [Abstract] [Full Text] [Related]

  • 17. [Serum concentrations and kinetics after intravenous infusion of four grams of cefazolin (author's transl)].
    Adam D, Pätzold J.
    Infection; 1977 Feb 15; 5(4):228-31. PubMed ID: 598929
    [Abstract] [Full Text] [Related]

  • 18. Studies on protein binding of antibiotics. II. Effect of apalcillin on protein binding and pharmacokinetics of cefoperazone and cefazolin.
    Watanabe Y, Hayashi T, Kitayama R, Yasuda T, Saikawa I, Shimizu K.
    J Antibiot (Tokyo); 1981 Jun 15; 34(6):753-7. PubMed ID: 6456252
    [Abstract] [Full Text] [Related]

  • 19. Study of the serum half-life of a new cephalosporin in uraemic patients.
    Fillastre JP, Humbert G, Acar J, Malandain H, Robert M, Dubois D, Daufresne MF.
    Proc Eur Dial Transplant Assoc; 1972 Jun 15; 9():577-80. PubMed ID: 4668933
    [No Abstract] [Full Text] [Related]

  • 20. Distribution in normal and inflammatory tissue of a new semisynthetic cephalosporin, SK&F 75073.
    Intoccia AP, Walkenstein SS, Joseph G, Wittendorf R, Girman C, Walz DT, Actor P, Weisbach J.
    J Antibiot (Tokyo); 1978 Nov 15; 31(11):1188-94. PubMed ID: 721712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.